ConductScience.org, home

Paper39487553

Ribosomal proteins in hepatocellular carcinoma: mysterious but promising.

Su Q and 6 others. Cell Biosci, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Ribosomal proteins in hepatocellular carcinoma: mysterious but promising. Papers, record 39487553. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39487553

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ribosomal proteins in hepatocellular carcinoma: mysterious but promising.
PubMed
Journal
Cell Biosci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.85, provisional
iCite
Revised in PubMed
2024-11-04
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Su QQian
2Sun HHuizhen
3Mei LLing
4Yan YYing
5Ji HHuimin
6Chang LLe
7Wang LLunan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No.7232142Natural Science Foundation of Beijing MunicipalityPubMed
No. 82202612National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References153

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133987350Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world.Ann Transl Med2021https://conductscience.org/library/papers/33987350PubMed
232395510High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection.Ann Transl Med2020https://conductscience.org/library/papers/32395510PubMed
336684217Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma.Front Surg2022https://conductscience.org/library/papers/36684217PubMed
428161490Structural analysis of ribosomal RACK1 and its role in translational control.Cell Signal2017https://conductscience.org/library/papers/28161490PubMed
529344114HNF-4α promotes multidrug resistance of gastric cancer cells through the modulation of cell apoptosis.Oncol Lett2017https://conductscience.org/library/papers/29344114PubMed
632316188Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.Cells2020https://conductscience.org/library/papers/32316188PubMed
726030272Mitochondrial ribosome assembly in health and disease.Cell Cycle2015https://conductscience.org/library/papers/26030272PubMed
824099156Transcriptional regulation by hypoxia inducible factors.Crit Rev Biochem Mol Biol2014https://conductscience.org/library/papers/24099156PubMed
937446035Cisplatin in Liver Cancer Therapy.Int J Mol Sci2023https://conductscience.org/library/papers/37446035PubMed
1016728594p53 regulates mitochondrial respiration.Science2006https://conductscience.org/library/papers/16728594PubMed
1117881366Human ribosomal protein S13 regulates expression of its own gene at the splicing step by a feedback mechanism.Nucleic Acids Res2007https://conductscience.org/library/papers/17881366PubMed
1236577883Silencing RPL8 inhibits the progression of hepatocellular carcinoma by down-regulating the mTORC1 signalling pathway.Hum Cell2023https://conductscience.org/library/papers/36577883PubMed
1336152386The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022.Eur J Med Chem2022https://conductscience.org/library/papers/36152386PubMed
1431886121The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.Anal Cell Pathol (Amst)2019https://conductscience.org/library/papers/31886121PubMed
1536549921GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels.Brief Bioinform2023https://conductscience.org/library/papers/36549921PubMed
1632627011Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.Oncol Rep2020https://conductscience.org/library/papers/32627011PubMed
1712368239Identification and analysis of over 2000 ribosomal protein pseudogenes in the human genome.Genome Res2002https://conductscience.org/library/papers/12368239PubMed
1821857917RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.PLoS One2011https://conductscience.org/library/papers/21857917PubMed
1912872448Phase II study to topotecan and cisplatin in advanced hepatocellular carcinoma.Korean J Intern Med2003https://conductscience.org/library/papers/12872448PubMed
209858605Ribosomal protein S14 of Saccharomyces cerevisiae regulates its expression by binding to RPS14B pre-mRNA and to 18S rRNA.Mol Cell Biol1999https://conductscience.org/library/papers/9858605PubMed

See all 153 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41977283SLC25A39 Upregulation Is Associated with DNA Methylation, Immune Cell Infiltration, and Poor Prognosis in Hepatocellular Carcinoma.Int J Mol Sci2026https://conductscience.org/library/papers/41977283PubMed
41777648RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression.Front Oncol2026https://conductscience.org/library/papers/41777648PubMed
40862733Interpretation of the Transcriptome-Based Signature of Tumor-Initiating Cells, the Core of Cancer Development, and the Construction of a Machine Learning-Based Classifier.Cells2025https://conductscience.org/library/papers/40862733PubMed
40792132TSPAN9 inhibits malignant progression of hepatocellular carcinoma.Transl Cancer Res2025https://conductscience.org/library/papers/40792132PubMed
40715829The role of mitochondria-related genes in hepatocellular carcinoma prognosis: construction of prognostic models based on machine learning.Discov Oncol2025https://conductscience.org/library/papers/40715829PubMed
40715580The role of glucocorticoids in hepatocellular carcinoma through integrated bioinformatics analysis and experimental validation.Sci Rep2025https://conductscience.org/library/papers/40715580PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39487553

GET https://conductscience.org/api/papers/v1/39487553/references?page=2